These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 21243321

  • 21. Stevens-Johnson syndrome due to strontium ranelate.
    Tan KW, Wang YS, Tay YK.
    Ann Acad Med Singap; 2011 Nov; 40(11):510-1. PubMed ID: 22206068
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
    Namazi H.
    Curr Med Res Opin; 2012 Apr; 28(4):609; author reply 609-10. PubMed ID: 22435797
    [No Abstract] [Full Text] [Related]

  • 30. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP.
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [Abstract] [Full Text] [Related]

  • 31. Strontium ranelate related Stevens-Johnson syndrome: a case report.
    Yang CY, Chen CH, Wang HY, Hsiao HL, Hsiao YH, Chung WH.
    Osteoporos Int; 2014 Jun; 25(6):1813-6. PubMed ID: 24687387
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).
    Landfeldt E, Lang A, Robbins S, Ström O.
    Calcif Tissue Int; 2011 Sep; 89(3):234-45. PubMed ID: 21695544
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Strontium ranelate].
    Masaki H, Miki T.
    Clin Calcium; 2006 Jan; 16(1):137-44. PubMed ID: 16397364
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.
    Hiligsmann M, Bruyère O, Reginster JY.
    Bone; 2010 Feb; 46(2):440-6. PubMed ID: 19716940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.